title: Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.
authors.affiliation: Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa. karims1@ukzn.ac.za
authors.forename: Salim S Abdool
authors.initials: SS
authors.lastname: Karim
authors.forename: Angela D M
authors.initials: AD
authors.lastname: Kashuba
authors.forename: Lise
authors.initials: L
authors.lastname: Werner
authors.forename: Quarraisha Abdool
authors.initials: QA
authors.lastname: Karim
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D000282:Administration, Intravaginal; D000284:Administration, Oral; D017954:Africa South of the Sahara / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism*; D044966:Anti-Retroviral Agents / Q000008:administration & dosage; D003075:Coitus; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D057239:Early Termination of Clinical Trials; D000068679:Emtricitabine; D005260:Female; D005782:Gels; D015658:HIV Infections / Q000453:epidemiology / Q000378:metabolism / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D063065:Organophosphonates / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism*; D011322:Primary Prevention / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012007:Rectum / Q000378:metabolism; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D000068698:Tenofovir; D013997:Time Factors; D014621:Vagina / Q000378:metabolism; D016387:Women's Health
chemical_list: D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D005782:Gels; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine